Current status of systemic chemotherapy in the treatment of advanced ovarian cancer with emphasis on CHAP-5

J. P. Nejit, W. W. ten Bokkel Huinink, M. E L van der Burg, A. T. van Oosterom, R. Vriesendrop, H. M. Pinedo

Research output: Contribution to journalArticle

Abstract

In patients with advanced ovarian cancer, initial treatment with combination chemotherapy, including cyclophosphamide and cis-platinum diamminedichloride (cis-platinum), produces response and progression-free survival results which are superior to those achieved with alkylating single-agent chemotherapy. Unfortunately most schedules have not resulted in a statistically significant improvement of overall survival. So far one of the most effective combination regimens is the four-drug regimen, CHAP-5 that consists of cyclophosphamide, hexamethylmelamine, adriamycin, and cis-platinum. This regimen is the first schedule to result in significant improved survival times compared with a second combination schedule, i.e. Hexa-CAF, which is at least as good as alkylating therapy alone. The CHAP-5 regimen was rather toxic but it was manageable and easy to apply in daily practice. Further improvement of the treatment results in advanced ovarian carcinoma will be difficult because no effective new drugs are available. In future clinical research it must be tried to decrease the toxicity and morbidity of the current schedules without reducing efficacy and survival.

Original languageEnglish (US)
Pages (from-to)19-29
Number of pages11
JournalRadiotherapy and Oncology
Volume2
Issue number1
DOIs
StatePublished - 1984
Externally publishedYes

Keywords

  • Chemotherapy
  • Ovarian cancer

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Urology

Fingerprint Dive into the research topics of 'Current status of systemic chemotherapy in the treatment of advanced ovarian cancer with emphasis on CHAP-5'. Together they form a unique fingerprint.

  • Cite this

    Nejit, J. P., ten Bokkel Huinink, W. W., van der Burg, M. E. L., van Oosterom, A. T., Vriesendrop, R., & Pinedo, H. M. (1984). Current status of systemic chemotherapy in the treatment of advanced ovarian cancer with emphasis on CHAP-5. Radiotherapy and Oncology, 2(1), 19-29. https://doi.org/10.1016/S0167-8140(84)80034-1